H. Perez

H. Perez

Director/Board Member at
Presidio Pharmaceuticals, Inc.
76 year
Health Technology
Consumer Services
Finance

Profile

H.
Daniel Perez
is the founder of Naia Rare Diseases LLC, which was founded in 2014.
He held the title of Chairman & Chief Executive Officer at Naia Rare Diseases LLC.
Currently, Dr. Perez is the Director at Presidio Pharmaceuticals, Inc. and the Professor at The University of California, San Francisco.
In the past, he was the President & Chief Executive Officer at Berlex Biosciences from 1993 to 2006.
He also served as the Chairman at Accelerated Pharma, Inc. from 2015 to 2016, Independent Director at Cleveland BioLabs, Inc. from 2006 to 2011, Director at Celtaxsys, Inc. from 2011 to 2013, Director at Hyperion Therapeutics, Inc., and Venture Partner at Bay City Capital LLC.
Dr. Perez obtained a doctorate degree from Universidad de Buenos Aires and an undergraduate degree from Universidad Mariano Egaña.

H. Perez active positions

CompaniesPositionStart
Corporate Officer/Principal -
Director/Board Member -

Former positions of H. Perez

CompaniesPositionEnd
ACCELERATED PHARMA INC Chairman 31/01/2016
STATERA BIOPHARMA, INC. Director/Board Member -
Berlex Biosciences
Chief Executive Officer 31/12/2005
Chief Executive Officer -
Chairman -
See the detail of H. Perez's experience

Training of H. Perez

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Consumer Services

Health Technology

Berlex Biosciences

Health Services